Nissui Pharmaceutical Co Ltd
TSE:4550

Watchlist Manager
Nissui Pharmaceutical Co Ltd Logo
Nissui Pharmaceutical Co Ltd
TSE:4550
Watchlist
Price: 999 999.9999 JPY
Market Cap: ¥38.3B

Relative Value

4550 price has not been updated for more than 2 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of Nissui Pharmaceutical Co Ltd.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Nissui Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Nissui Pharmaceutical Co Ltd
TSE:4550
38.3B JPY 2.2 37.9 20.6 23.8
JP
Hoya Corp
TSE:7741
8.6T JPY 9.7 41.3 25.6 30.7
CH
Alcon AG
SIX:ALC
30.4B CHF 3.8 37.3 19.6 38
US
Medline Inc
NASDAQ:MDLN
36.4B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
119.9B DKK 4.3 33 15.2 18.1
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD 3 32 14.5 18.4
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.8 29.9 18 29.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY 9.4 25.8 23.2 23.2
KR
HLB Inc
KOSDAQ:028300
8.7T KRW 97.1 -35.6 -89.1 -84.3
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.7 19.6 92.4
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF 5.4 22.1 14.3 19.4
P/E Multiple
Earnings Growth PEG
JP
Nissui Pharmaceutical Co Ltd
TSE:4550
Average P/E: 32.4
37.9
N/A N/A
JP
Hoya Corp
TSE:7741
41.3
13%
3.2
CH
Alcon AG
SIX:ALC
37.3
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
32
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.9
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.8
9%
2.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -35.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
22.1
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Nissui Pharmaceutical Co Ltd
TSE:4550
Average EV/EBITDA: 19
20.6
N/A N/A
JP
Hoya Corp
TSE:7741
25.6
11%
2.3
CH
Alcon AG
SIX:ALC
19.6
8%
2.4
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.2
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.5
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
18
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.2
15%
1.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -89.1 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.3
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Nissui Pharmaceutical Co Ltd
TSE:4550
Average EV/EBIT: 32.6
23.8
N/A N/A
JP
Hoya Corp
TSE:7741
30.7
N/A N/A
CH
Alcon AG
SIX:ALC
38
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.1
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.4
16%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.2
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.2
11%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -84.3 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
92.4
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19.4
29%
0.7